The president of Dominican Medical College (CMD)Faustino Senén Caba, favored the Government taking legal action against the pharmaceutical company AstraZeneca under the allegation that it has not complied with the delivery of the vaccines against covid-19 that it promised to supply to the country.
Senen Caba assured, at the end of his participation in an act in the Autonomous University of Santo Domingo (UASD)affirmed that the country remained for “more than four months” waiting for the vaccines from that pharmaceutical company during the most intense period of the pandemic and that these compounds “never” arrived.
He affirmed that due to this lack in the contract signed by the Dominican Government with AstraZeneca “many” Dominicans died and others have been left in a condition of disability.
Last Wednesday, the deputy minister of Collective Health, Eladio Pérezannounced that the Government and the pharmaceutical company were in contact with the proposal of the Dominican authorities to exchange the almost nine million vaccines that it has not delivered to the country, in exchange for medications for hypertension and diabetes.
In October 2020, the Dominican Government signed an agreement with the British biopharmaceutical company AstraZeneca to acquire 10 million doses of its candidate vaccine against Covid-19, developed together with the Oxford University.
President Luis Abinader led the signing ceremony held at the National Palace. On that occasion, the head of state said that it was an advance purchase contract for the potential supply of the biological in the national territory.
He said that the total investment will be 40 million dollars, four dollars per vaccine. The first payment of 8 million dollars was provided by the private sector, added the president.
However, AstraZeneca has only delivered 879,600 doses to the country. From that lot, the Dominican Republic donated more than 400,000 compounds to Honduras and Guatemala.
Abinader recently said that the Government is considering taking legal action against the pharmaceutical company for breach of contract
–
